{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:28:19Z","timestamp":1787898499161,"version":"build-2784847793"},"reference-count":89,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2013,9,16]],"date-time":"2013-09-16T00:00:00Z","timestamp":1379289600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0073631","type":"journal-article","created":{"date-parts":[[2013,9,16]],"date-time":"2013-09-16T21:25:18Z","timestamp":1379366718000},"page":"e73631","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["Investigating Interventions in Alzheimer's Disease with Computer Simulation Models"],"prefix":"10.1371","volume":"8","author":[{"given":"Carole J.","family":"Proctor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Boche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A. R.","family":"Nicoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,9,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1093\/hmg\/ddq160","article-title":"Molecular mechanisms of neurodegeneration in Alzheimer&apos;s disease","volume":"19","author":"L Crews","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","article-title":"Safety, efficacy, and biomarker findings of PBT2 in targeting A\u03b2 as a modifying therapy for Alzheimer&apos;s disease: a phase IIa, double-blind, randomised, placebo-controlled trial","volume":"7","author":"L Lannfelt","year":"2008","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"D Schenk","year":"1999","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1212\/WNL.0b013e3181c67808","article-title":"A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease","volume":"73","author":"S Salloway","year":"2009","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0896-6273(03)00294-0","article-title":"Antibodies against beta-amyloid slow cognitive decline in Alzheimer&apos;s disease","volume":"38","author":"C Hock","year":"2003","journal-title":"Neuron"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/01.WNL.0000148604.77591.67","article-title":"Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD","volume":"64","author":"AJ Bayer","year":"2005","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization","volume":"61","author":"JM Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","article-title":"Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer&apos;s Association Research Roundtable Workgroup","volume":"7","author":"RA Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nm.2224","article-title":"The benefits and limitations of animal models for translational research in neurodegenerative diseases","volume":"16","author":"M Jucker","year":"2010","journal-title":"Nat Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00401-010-0719-5","article-title":"Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer&apos;s disease pathogenesis","volume":"120","author":"D Boche","year":"2010","journal-title":"Acta Neuropathol (Berl)"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of Abeta42 immunisation in Alzheimer&apos;s disease: follow-up of a randomised, placebo-controlled phase I trial","volume":"372","author":"C Holmes","year":"2008","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/01.jnen.0000240466.10758.ce","article-title":"Abeta species removal after Abeta42 immunization","volume":"65","author":"JA Nicoll","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm840","article-title":"Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report","volume":"9","author":"JA Nicoll","year":"2003","journal-title":"Nat Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1474-4422(10)70043-0","article-title":"11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer&apos;s disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study","volume":"9","author":"JO Rinne","year":"2010","journal-title":"Lancet Neurol"},{"key":"ref15","article-title":"Microglial alterations in human Alzheimer&apos;s disease following Abeta42 immunisation","author":"E Zotova","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-5-39","article-title":"The biochemical aftermath of anti-amyloid immunotherapy","volume":"5","author":"C Maarouf","year":"2010","journal-title":"Mol Neurodegener"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-010-0705-y","article-title":"Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer&apos;s disease","volume":"120","author":"D Boche","year":"2010","journal-title":"Acta Neuropathol (Berl)"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/brain\/awq056","article-title":"Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology","volume":"133","author":"A Serrano-Pozo","year":"2010","journal-title":"Brain"},{"key":"ref19","first-page":"22","article-title":"Lower glycogen synthase kinase-3beta load in Alzheimer&apos;s disease after Abeta42 immunization","volume":"37","author":"AM Baker","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1326-5-7","article-title":"GSK3 and p53 - is there a link in Alzheimer&apos;s disease?","volume":"5","author":"C Proctor","year":"2010","journal-title":"Mol Neurodegener"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00726-009-0319-7","article-title":"Generation of reactive oxygen species by beta amyloid fibrils and oligomers involves different intra\/extracellular pathways","volume":"38","author":"C Giovanna","year":"2010","journal-title":"Amino Acids"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1126\/science.1091230","article-title":"ABAD directly links Abeta to mitochondrial toxicity in Alzheimer&apos;s disease","volume":"304","author":"JW Lustbader","year":"2004","journal-title":"Science"},{"key":"ref23","first-page":"04-2637fje","article-title":"Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer&apos;s disease","author":"Y Ohyagi","year":"2004","journal-title":"FASEB J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.neurobiolaging.2007.04.014","article-title":"A\u03b2 inhibits the proteasome and enhances amyloid and tau accumulation","volume":"29","author":"BP Tseng","year":"2008","journal-title":"Neurobiol Aging"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1110\/ps.04847404","article-title":"Urea modulation of beta-amyloid fibril growth: Experimental studies and kinetic models","volume":"13","author":"JR Kim","year":"2004","journal-title":"Protein Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0006-3495(01)75831-6","article-title":"A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state","volume":"81","author":"MM Pallitto","year":"2001","journal-title":"Biophys J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1006\/bulm.2002.0304","article-title":"A mathematical model of the impact of novel Treatments on the Abeta burden in the Alzheimers brain, CSF and plasma","volume":"64","author":"DL Craft","year":"2002","journal-title":"Bull Math Biol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1212\/WNL.41.4.469","article-title":"Very mild Alzheimer&apos;s disease: informant-based clinical, psychometric, and pathologic distinction from normal aging","volume":"41","author":"JC Morris","year":"1991","journal-title":"Neurology"},{"key":"ref29","first-page":"21","article-title":"Relative roles of plaques and tangles in the dementia of Alzheimer&apos;s disease: correlations using three sets of neuropathological criteria","volume":"6","author":"Z Nagy","year":"1995","journal-title":"Dementia"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/NEN.0b013e3181aacbe9","article-title":"Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease","volume":"68","author":"PT Nelson","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0022-510X(82)90155-1","article-title":"Plaques, tangles and dementia. A quantitative study","volume":"56","author":"GK Wilcock","year":"1982","journal-title":"J Neurol Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuron.2008.11.007","article-title":"Linking Abeta and tau in late-onset Alzheimer&apos;s disease: a dual pathway hypothesis","volume":"60","author":"SA Small","year":"2008","journal-title":"Neuron"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-\u03b2 toxicity in Alzheimer&apos;s disease mouse models","volume":"142","author":"LM Ittner","year":"2010","journal-title":"Cell"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1073\/pnas.092136199","article-title":"Tau is essential to beta-amyloid-induced neurotoxicity","volume":"99","author":"M Rapoport","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer&apos;s disease mouse model","volume":"316","author":"ED Roberson","year":"2007","journal-title":"Science"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/bioinformatics\/btg015","article-title":"The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models","volume":"19","author":"M Hucka","year":"2003","journal-title":"Bioinformatics"},{"key":"ref37","unstructured":"The Systems Biology Markup Language <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.sbml.org\" xlink:type=\"simple\">www.sbml.org<\/ext-link>. Accessed 2013 Aug 1"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"20324","DOI":"10.1073\/pnas.0911281106","article-title":"Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide","volume":"106","author":"X Hu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer&apos;s disease","volume":"330","author":"KG Mawuenyega","year":"2010","journal-title":"Science"},{"key":"ref40","unstructured":"Alzheimer Research Forum <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.alzforum.org\/new\/detail.asp?id=3268\" xlink:type=\"simple\">http:\/\/www.alzforum.org\/new\/detail.asp?id=3268<\/ext-link>. Accessed 2013 Aug 1"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1326-7-32","article-title":"Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer&apos;s disease: a stochastic modelling approach","volume":"7","author":"CJ Proctor","year":"2012","journal-title":"Mol Neurodegener"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.2353\/ajpath.2006.060269","article-title":"Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer&apos;s disease patients: a biochemical analysis","volume":"169","author":"RL Patton","year":"2006","journal-title":"Am J Pathol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1073\/pnas.122062299","article-title":"Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage","volume":"99","author":"P Watcharasit","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/bioinformatics\/btl485","article-title":"COPASI\u2013a COmplex PAthway SImulator","volume":"22","author":"S Hoops","year":"2006","journal-title":"Bioinformatics"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer&apos;s disease","volume":"12","author":"J Hardy","year":"1991","journal-title":"Trends Pharmacol Sci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer&apos;s disease","volume":"6","author":"DJ Selkoe","year":"1991","journal-title":"Neuron"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1471-2202-11-144","article-title":"Protein aggregation containing beta-amyloid, alpha-synuclein and hyperphosphorylated tau in cultured cells of hippocampus, substantia nigra and locus coeruleus after rotenone exposure","volume":"11","author":"RS Chaves","year":"2010","journal-title":"BMC Neurosci"},{"key":"ref48","article-title":"A unifying hypothesis for familial and sporadic Alzheimer&apos;s disease","author":"CJ Proctor","year":"2012","journal-title":"Int J Alzheimers Dis 2012"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1326-4-13","article-title":"The role of tau in neurodegeneration","volume":"4","author":"T Gendron","year":"2009","journal-title":"Mol Neurodegener"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer&apos;s disease","volume":"104","author":"C Hooper","year":"2008","journal-title":"J Neurochem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2007.03.026","article-title":"p53 is upregulated in Alzheimer&apos;s disease and induces tau phosphorylation in HEK293a cells","volume":"418","author":"C Hooper","year":"2007","journal-title":"Neurosci Lett"},{"key":"ref52","first-page":"595","article-title":"The role of tau kinases in Alzheimer&apos;s disease","volume":"13","author":"PJ Dolan","year":"2010","journal-title":"Curr Opin Drug Discov Devel"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer&apos;s brains impair synaptic plasticity and memory","volume":"14","author":"GM Shankar","year":"2008","journal-title":"Nat Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"15157","DOI":"10.1021\/bi061850f","article-title":"Solution State Characterization of Amyloid \u03b2-Derived Diffusible Ligands","volume":"45","author":"RW Hepler","year":"2006","journal-title":"Biochemistry (Mosc)"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2008.02.003","article-title":"Endocytosis is required for synaptic activity-dependent release of amyloid-\u03b2 in vivo","volume":"58","author":"JR Cirrito","year":"2008","journal-title":"Neuron"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3233\/JAD-2010-101020","article-title":"Amyloid-beta as a modulator of synaptic plasticity","volume":"22","author":"MS Parihar","year":"2010","journal-title":"J Alzheimer's Dis"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer&apos;s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"S Oddo","year":"2003","journal-title":"Neuron"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuron.2004.07.003","article-title":"Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome","volume":"43","author":"S Oddo","year":"2004","journal-title":"Neuron"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1517\/17460441.2012.666234","article-title":"The value and limitations of transgenic mouse models used in drug discovery for Alzheimer&apos;s disease: an update","volume":"7","author":"KR Bales","year":"2012","journal-title":"Expert Opin Drug Discov"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.1073\/pnas.1201209109","article-title":"Postsynaptic dysfunction is associated with spatial and object recognition memory loss in a natural model of Alzheimer&apos;s disease","volume":"109","author":"AO Ardiles","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1523\/JNEUROSCI.4321-06.2007","article-title":"Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer&apos;s disease are associated with reduced amyloid precursor protein phosphorylation","volume":"27","author":"E Rockenstein","year":"2007","journal-title":"J Neurosci"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1172\/JCI37873","article-title":"NFAT\/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy","volume":"120","author":"R Gomez-Sintes","year":"2010","journal-title":"J Clin Invest"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"e29102","DOI":"10.1371\/journal.pone.0029102","article-title":"Resveratrol protects rats from Abeta-induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation","volume":"6","author":"TC Huang","year":"2011","journal-title":"PLoS ONE"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/387296a0","article-title":"Mdm2 promotes the rapid degradation of p53","volume":"387","author":"Y Haupt","year":"1997","journal-title":"Nature"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"48872","DOI":"10.1074\/jbc.M305870200","article-title":"Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53","volume":"278","author":"P Watcharasit","year":"2003","journal-title":"J Biol Chem"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0014-5793(99)00685-7","article-title":"Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration","volume":"453","author":"G Alvarez","year":"1999","journal-title":"FEBS Lett"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0306-4522(94)90400-6","article-title":"Dephosphorylation of Alzheimer&apos;s disease abnormally phosphorylated tau by protein phosphatase-2A","volume":"61","author":"CX Gong","year":"1994","journal-title":"Neuroscience"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11064-006-9128-5","article-title":"Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics","volume":"32","author":"RS Jope","year":"2007","journal-title":"Neurochem Res"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"D689","DOI":"10.1093\/nar\/gkj092","article-title":"BioModels Database: a free, centralized database of curated, published, quantitative kinetic models of biochemical and cellular systems","volume":"34","author":"N Le Novere","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1523\/JNEUROSCI.23-09-03745.2003","article-title":"Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation","volume":"23","author":"DM Wilcock","year":"2003","journal-title":"J Neurosci"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0304-3940(90)90748-X","article-title":"Morphologic association between microglia and senile plaque amyloid in Alzheimer&apos;s disease","volume":"119","author":"LS Perlmutter","year":"1990","journal-title":"Neurosci Lett"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","article-title":"Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease","volume":"6","author":"F Bard","year":"2000","journal-title":"Nat Med"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00011.2010","article-title":"Physiology of microglia","volume":"91","author":"H Kettenmann","year":"2011","journal-title":"Physiol Rev"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1523\/JNEUROSCI.17-07-02284.1997","article-title":"Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia","volume":"17","author":"DR McDonald","year":"1997","journal-title":"J Neurosci"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1073\/pnas.94.8.4109","article-title":"Disaggregation of Alzheimer \u03b2-amyloid by site-directed mAb","volume":"94","author":"B Solomon","year":"1997","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1474-4422(03)00349-1","article-title":"Immunotherapy for Alzheimer&apos;s disease","volume":"2","author":"RC Dodel","year":"2003","journal-title":"Lancet Neurol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nan.12011","article-title":"Review: Activation patterns of microglia and their identification in the human brain","volume":"39","author":"D Boche","year":"2013","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/bi951685w","article-title":"In vitro growth of Alzheimer&apos;s disease \u03b2-amyloid plaques displays first-order kinetics","volume":"35","author":"WP Esler","year":"1996","journal-title":"Biochemistry (Mosc)"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"10424","DOI":"10.1021\/bi990718v","article-title":"Deposition of monomeric, not oligomeric, A\u03b2 mediates growth of Alzheimer&apos;s disease amyloid plaques in human brain preparations","volume":"38","author":"BP Tseng","year":"1999","journal-title":"Biochemistry (Mosc)"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/00005072-199311000-00006","article-title":"The lack of accumulation of senile plaques or amyloid burden in Alzheimer&apos;s disease suggests a dynamic balance between amyloid deposition and resolution","volume":"52","author":"BT Hyman","year":"1993","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1073\/pnas.89.12.5462","article-title":"Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide","volume":"89","author":"JE Maggio","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1073\/pnas.94.14.7612","article-title":"Aggregation and disaggregation of senile plaques in Alzheimer disease","volume":"94","author":"L Cruz","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"7302","DOI":"10.1038\/sj.onc.1210542","article-title":"Amyloid-[beta] precursor-like protein APLP1 is a novel p53 transcriptional target gene that augments neuroblastoma cell death upon genotoxic stress","volume":"26","author":"X Tang","year":"2007","journal-title":"Oncogene"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/jnr.22796","article-title":"Localization of mature neprilysin in lipid rafts","volume":"90","author":"K Sato","year":"2012","journal-title":"J Neurosci Res"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/NEN.0b013e3182345e46","article-title":"Abeta-degrading enzymes: potential for treatment of Alzheimer disease","volume":"70","author":"JS Miners","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/bioinformatics\/btl485","article-title":"COPASI - a COmplex PAthway SImulator","volume":"22","author":"S Hoops","year":"2006","journal-title":"Bioinformatics"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Wilkinson DJ (2006) Stochastic Modelling for Systems Biology: Chapman &amp; Hall\/CRC Press.","DOI":"10.1201\/9781420010664"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1021\/j100540a008","article-title":"Exact stochastic simulation of coupled chemical reactions","volume":"31","author":"DT Gillespie","year":"1977","journal-title":"J Phys Chem"},{"key":"ref89","doi-asserted-by":"crossref","unstructured":"Wickham H (2009) ggplot2: elegant graphics for data analysis. : Springer New York.","DOI":"10.1007\/978-0-387-98141-3"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0073631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T08:02:33Z","timestamp":1646553753000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0073631"}},"subtitle":[],"editor":[{"given":"Jaya","family":"Padmanabhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,9,16]]},"references-count":89,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0073631","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,16]]}}}